Pharmaceutical export is unlikely to respond to Japanese earthquake

Korea will not benefit from Japan’s earthquake, while shares of domestic drugmakers such as CJ Cheil Jedang and Jeil Pharmaceutical are forecast to see gains, as growing demand for vaccines and antibiotics are expected to be on the increase.

“Although Japan was hit by the massive earthquake, Japan’s pharmaceutical manufacturing capability would be unaffected as the majority of drug productio...